Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway

European Journal of Pharmacology

Volumn 746, Issue , 2015, Pages 106-114

  Shatanawi, Alia ^a,b   Lemtalsi, Tahira ^b   Yao, Lin ^b   Patel, Chintan ^b   Caldwell, Ruth B ^b,c   Caldwell, R William ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Arginase; ATF 2; Nitric oxide (NO); p38 MAPK; Transcription factors

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOTENSIN II; ARGINASE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN C JUN; SMALL INTERFERING RNA; ARGINASE; LUCIFERASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BOVINE AORTIC ENDOTHELIAL CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WILD TYPE; ANIMAL; AORTA; BINDING SITE; BIOSYNTHESIS; BOVINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOTENSIN II; ANIMALS; AORTA; ARGINASE; BINDING SITES; CATTLE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUCIFERASES; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84949116884     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.10.042     Document Type: Article

References (32)

1. S. Archer Measurement of nitric oxide in biological models Faseb. J. 7 1993 349 360
2. T. Bachetti, L. Comini, G. Francolini, D. Bastianon, B. Valetti, M. Cadei, P. Grigolato, H. Suzuki, D. Finazzi, A. Albertini, S. Curello, and R. Ferrari Arginase pathway in human endothelial cells in pathophysiological conditions J. Mol. Cell Cardiol. 37 2004 515 523
3. T. Bagnost, A. Berthelot, M. Bouhaddi, P. Laurant, C. Andre, Y. Guillaume, and C. Demougeot Treatment with the arginase inhibitor N(omega)-hydroxy-nor-l-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat J. Hypertens. 26 2008 1110 1118
4. D.E. Berkowitz, R. White, D. Li, K.M. Minhas, A. Cernetich, S. Kim, S. Burke, A.A. Shoukas, D. Nyhan, H.C. Champion, and J.M. Hare Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels Circulation 108 2003 2000 2006
5. T.J. Bivalacqua, A.L. Burnett, W.J. Hellstrom, and H.C. Champion Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase Am. J. Physiol. Heart Circ. Physiol. 292 2007 H1340 H1351
6. S. Chandra, M.J. Romero, A. Shatanawi, A.M. Alkilany, R.B. Caldwell, and R.W. Caldwell Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway Br. J. Pharmacol. 165 2012 506 519
7. I.M. Corraliza, M.L. Campo, G. Soler, and M. Modolell Determination of arginase activity in macrophages: a micromethod J. Immunol. Methods 174 1994 231 235
8. C. Demougeot, A. Prigent-Tessier, C. Marie, and A. Berthelot Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats J. Hypertens. 23 2005 971 978
9. X. Gao, X. Xu, S. Belmadani, Y. Park, Z. Tang, A.M. Feldman, W.M. Chilian, and C. Zhang TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury Arterioscler Thromb. Vasc. Biol. 27 2007 1269 1275
10. M.J. Gray, M. Poljakovic, D. Kepka-Lenhart, and S.M. Morris Jr. Induction of arginase I transcription by Il-4 requires a composite DNA response element for STAT6 and C/EBPbeta Gene 353 2005 98 106
11. M. Hultstrom, F. Helle, and B.M. Iversen AT(1) receptor activation regulates the mRNA expression of CAT1, CAT2, arginase-1, and DDAH2 in preglomerular vessels from angiotensin II hypertensive rats Am. J. Physiol. Renal Physiol. 297 2009 F163 F168
12. R.K. Iyer, P.K. Yoo, R.M. Kern, N. Rozengurt, R. Tsoa, W.E. O'Brien, H. Yu, W.W. Grody, and S.D. Cederbaum Mouse model for human arginase deficiency Mol. Cell Biol. 22 2002 4491 4498
13. G. Jeyabalan, J.R. Klune, A. Nakao, N. Martik, G. Wu, A. Tsung, and D.A. Geller Arginase blockade protects against hepatic damage in warm ischemia-reperfusion Nitric Oxide 19 2008 29 35
14. M. Kimura IRF2-binding protein-1 is a JDP2 ubiquitin ligase and an inhibitor of ATF2-dependent transcription FEBS Lett. 582 2008 2833 2837
15. C. Livingstone, G. Patel, and N. Jones ATF-2 contains a phosphorylation-dependent transcriptional activation domain EMBO J. 14 1995 1785 1797
16. P. Lopez-Bergami, E. Lau, and Z. Ronai Emerging roles of ATF2 and the dynamic AP1 network in cancer Nat. Rev. Cancer 10 2010 65 76
17. C.R. Morris, G.J. Kato, M. Poljakovic, X. Wang, W.C. Blackwelder, V. Sachdev, S.L. Hazen, E.P. Vichinsky, S.M. Morris Jr., and M.T. Gladwin Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease JAMA 294 2005 81 90
18. K. Niwano, M. Arai, N. Koitabashi, S. Hara, A. Watanabe, K. Sekiguchi, T. Tanaka, T. Iso, and M. Kurabayashi Competitive binding of CREB and ATF2 to cAMP/ATF responsive element regulates eNOS gene expression in endothelial cells Arterioscler Thromb. Vasc. Biol. 26 2006 1036 1042
19. C.R. Pradeep, and G. Kuttan Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells Int. Immunopharmacol. 4 2004 1795 1803
20. J. Raingeaud, S. Gupta, J.S. Rogers, M. Dickens, J. Han, R.J. Ulevitch, and R.J. Davis Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine J. Biol. Chem. 270 1995 7420 7426
21. M.J. Romero, D.H. Platt, R.B. Caldwell, and R.W. Caldwell Therapeutic use of citrulline in cardiovascular disease Cardiovascular drug reviews 24 2006 275 290
22. M.J. Romero, D.H. Platt, H.E. Tawfik, M. Labazi, A.B. El-Remessy, M. Bartoli, R.B. Caldwell, and R.W. Caldwell Diabetes-induced coronary vascular dysfunction involves increased arginase activity Circ. Res. 102 2008 95 102
23. K.D. Sarge, S.P. Murphy, and R.I. Morimoto Activation of Heat-Shock Gene-Transcription by Heat-Shock Factor-I involves oligomerization, acquisition of DNA-binding activity, and nuclear-localization and can occur in the absence of stress (Vol 13, Pg 1394, 1993) Mol. Cell. Biol. 13 1993 3838 3839
24. M. Satoh, S. Fujimoto, S. Arakawa, T. Yada, T. Namikoshi, Y. Haruna, H. Horike, T. Sasaki, and N. Kashihara Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy Nephrol. Dial. Transplant 23 2008 3806 3813
25. N. Serrat, S. Pereira-Lopes, M. Comalada, J. Lloberas, and A. Celada Deacetylation of C/EBPbeta is required for Il-4-induced arginase-1 expression in murine macrophages Eur. J. Immunol. 42 2012 3028 3037
26. H.S. Sharma, H.A.A. Vanheugten, M.A. Goedbloed, P.D. Verdouw, and J.M.J. Lamers Angiotensin-Ii-induced expression of transcription factors precedes increase in transforming growth-factor-beta-1 messenger-Rna in neonatal cardiac fibroblasts Biochem. Bioph. Res. Co. 205 1994 105 112
27. A. Shatanawi, M.J. Romero, J.A. Iddings, S. Chandra, N.S. Umapathy, A.D. Verin, R.B. Caldwell, and R.W. Caldwell Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway Am. J. Physiol. Cell Physiol. 300 2011 C1181 C1192
28. M. Takiguchi, Y. Haraguchi, and M. Mori Human liver-type arginase gene: structure of the gene and analysis of the promoter region Nucl. Acids Res. 16 1988 8789 8802
29. H.A. Toque, M.J. Romero, R.C. Tostes, A. Shatanawi, S. Chandra, Z.N. Carneiro, E.W. Inscho, R.C. Webb, R.B. Caldwell, and R.W. Caldwell p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice J. Sex. Med. 7 2010 3857 3867
30. L. Yang, C.M. Lewis, U.M. Chandrasekharan, C.M. Kinney, P.E. Dicorleto, and V.S. Kashyap Arginase activity is increased by thrombin: a mechanism for endothelial dysfunction in arterial thrombosis J. Am. Coll. Surg. 203 2006 817 826
31. Z. Yang, and X.F. Ming Endothelial arginase: a new target in atherosclerosis Curr. Hypertens. Rep. 8 2006 54 59
32. W. Zhu, U.M. Chandrasekharan, S. Bandyopadhyay, S.M. Morris Jr., P.E. DiCorleto, and V.S. Kashyap Thrombin induces endothelial arginase through AP-1 activation Am. J. Physiol. Cell Physiol. 298 2009 C952 C960